Impact of Cytogenetics, Induction Chemotherapy and MRD on Outcomes of Intensively Treated AML with KMT2A Rearrangements - Experience from UK NCRI AML17 and AML19Jad Othman,Nicola Potter,Sylvie D Freeman,Nicholas McCarthy,Jelena Jovanovic,Manohursingh Runglall,Joanna Canham,Ian Thomas, Sean Johnson, Jamie Cavenagh,Panagiotis Kottaridis,David Taussig,Claire Arnold,Claire Hemmaway, Dominic J. Culligan,Ulrik Malthe Overgaard, Alan K. Burnett, Mike Dennis,Richard Dillon, Nigel H. RussellBlood（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
